ACRV
Acrivon Therapeutics, Inc.
1.90$
+1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.0% | +50.3% | +1.8% | +10.1% | +20.7% | +2.6% | -47.9% | +115.4% | +3.4% | +6.1% | +5.7% | – | |
| – | -5.3% | +9.4% | +6.6% | +2.9% | +1.0% | +2.3% | +3.6% | -0.4% | -21.0% | -29.4% | +1.5% | – | |
| – | +126.0% | -191.5% | – | +9.8% | -2.3% | -281.8% | – | +2,719.2% | -106.8% | – | – | – | |
| – | – | -29.2% | -83.2% | +621.9% | -16.4% | -93.0% | +750.0% | +82.4% | -75.6% | -93.6% | +521.4% | – | |
| – | +1,254.6% | -71.5% | -1,605.0% | – | -10.0% | +33.3% | +1.2% | -69.6% | +264.1% | -39.0% | +13.9% | – | |
| – | -2,678.2% | -91.4% | – | -101.2% | -57.0% | -47.0% | -71.7% | +20.6% | +64.1% | -82.8% | – | – | |
| – | – | -285.3% | – | -113.2% | – | – | – | -336.5% | – | -222.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.